Kedaara Capital
General
Grapevine: Kedaara to join Dream11 funding; 100% FDI likely in finished housing projects
Homegrown Kedaara Capital is vying for a spot in the $200 million (about Rs 1,500 crore) fundraising exercise of fantasy ......
General
Grapevine: ShareChat eyes funds from SAIF; Axis Bank in talks for PE funding
Regional language social media platform ShareChat is looking to raise $200 million (Rs 1,510 crore at current exchange rate) from...
Finance
Kedaara Capital opts for bigger stake in health insurance bet
Homegrown private equity firm Kedaara Capital has made a bigger bet on a healthcare insurance company than what was earlier ......
Finance
Sarva Capital scores multi-bagger exit from non-bank lender
Venture capital fund Sarva Capital has made a multi-bagger exit from its five-year-old investment in a non-banking finance company...
Finance
Bank mergers keep financial sector in focus but PE deals slip again in Jan-March
India’s banking, financial services and insurance (BFSI) sector recorded seven big mergers in the first quarter of 2020...
Finance
Fund Scan: Can Kedaara Capital stay the course as coronavirus shakes portfolio firms?
Last month, private equity firm Kedaara Capital added a non-bank lender to its portfolio. At any other time the investment ......
Finance
Veritas Finance raises Series E funding from Kedaara Capital, others
Veritas Finance Pvt. Ltd has raised Rs 350 crore ($46 million at current exchange rates) in its Series E round ......
Finance
How the rupee's slide after the virus outbreak may hurt PE, VC firms
Ever since the coronavirus outbreak became a global pandemic, world markets have been in turmoil. The pandemic, which has already...
General
Grapevine: Apax, others eye CSS Corp; Adani may infuse funds in Simplex Infra
Private equity funds including Apax Partners and Kedaara Capital are in early discussions to acquire US-headquartered IT company...
Healthcare
Kedaara Capital backs Gujarat life sciences firm in first pharma bet
Homegrown private equity firm Kedaara Capital has made its first pharmaceuticals bet with an investment in a bulk-drugs maker...
